SCHEMBL22924968

SCHEMBL22924968

CCCCOC(=O)C(c1ccnc(N(Cc2ccc(OC)cc2)S(=O)(=O)C2CC2)n1)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 11/20 0.35
CNR2 P34972 1/20 0.34
CHRM2 P08172 1/20 0.34
CHRM1 P11229 1/20 0.34
TAS2R14 Q9NYV8 2/20 0.33
USP2 O75604 2/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
MMP1 P03956 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP7 P09237 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP13 P45452 1/20 0.33
CTSD P07339 1/20 0.33
PTGES O14684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30416333 0.90 APLNR (0.38) APLNRTAS2R14MMP2MMP9MMP8
SCHEMBL21392057 0.90 APLNR (0.38) APLNRTAS2R14MMP2MMP9MMP8
SCHEMBL22924965 0.88 APLNR (0.38) APLNRTAS2R14MMP2MMP9MMP8
SCHEMBL29228057 0.87 APLNR (0.38) APLNRTAS2R14MMP2MMP9MMP8
Potassium SCHEMBL30882859 0.87 APLNR (0.38) APLNRTAS2R14MMP2MMP9MMP8
Potassium Ion SCHEMBL28474917 0.86 APLNR (0.37) APLNRTAS2R14MMP2MMP9MMP8
Potassium Ion SCHEMBL30725705 0.86 APLNR (0.37) APLNRTAS2R14MMP2MMP9MMP8
SCHEMBL21392069 0.81 APLNR (0.36) APLNRTAS2R14PTGES
SCHEMBL30416047 0.81 APLNR (0.36) APLNRTAS2R14PTGES
SCHEMBL25778783 0.79 APLNR (0.37) APLNRCNR2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024507-A1 Compounds STEP PHARMA S A S (FR) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024507-A1 Compounds CYP1A1, UGT1A1, CYP1A2 APLNR 3512/4885CNR2 1312/4885CHRM2 3228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.